The transcription factor HNF4␣ (hepatocyte nuclear factor-4␣) is required for increased ␤-cell proliferation during metabolic stress in vivo. We hypothesized that HNF4␣ could induce proliferation of human ␤-cells. We employed adenoviral-mediated overexpression of an isoform of HNF4␣ (HNF4␣8) alone, or in combination with cyclin-dependent kinase (Cdk)6 and Cyclin D3, in human islets. Heightened HNF4␣8 expression led to a 300-fold increase in the number of ␤-cells in early S-phase. When we overexpressed HNF4␣8 together with Cdk6 and Cyclin D3, ␤-cell cycle entry was increased even further. However, the punctate manner of bromodeoxyuridine incorporation into HNF4␣ High ␤-cells indicated an uncoupling of the mechanisms that control the concise timing and execution of each cell cycle phase. Indeed, in HNF4␣8-induced bromodeoxyuridine ϩ,punctate ␤-cells we observed signs of dysregulated DNA synthesis, cell cycle arrest, and activation of a double stranded DNA damage-associated cell cycle checkpoint mechanism, leading to the initiation of loss of ␤-cell lineage fidelity. However, a substantial proportion of ␤-cells stimulated to enter the cell cycle by Cdk6 and Cyclin D3 alone also exhibited a DNA damage response. HNF4␣8 is a mitogenic signal in the human ␤-cell but is not sufficient for completion of the cell cycle. The DNA damage response is a barrier to efficient ␤-cell proliferation in vitro, and we suggest its evaluation in all attempts to stimulate ␤-cell replication as an approach to diabetes treatment. (Molecular Endocrinology 26: 1590 -1602, 2012) NURSA Molecule Pages † : Nuclear Receptors: HNF4-␣.
phase); and 3) progression through the remaining cell cycle phases (G 2 -and M-phase). Thus far, only overexpression of the winged helix transcription factor FoxM1 (4), or combinations of a G 1 /S-phase specific cyclin-dependent kinase (Cdk) with its D-type cyclin partner have shown progression through multiple phases of the cell cycle in adult human ␤-cells, with Cdk6 overexpression translating to continued ␤-cell replication in the face of hyperglycemia in vivo (5) . In addition, even if a factor is sufficient to induce progression through one complete cell cycle, protection of the newly formed ␤-cells from apoptosis must also be achieved (6) .
One potential sufficiency factor is hepatocyte nuclear factor (HNF) 4␣ (mutated in MODY1), because its transcriptional activity is required for the physiological increase of ␤-cell replication during murine pregnancy, and glucose stimulated insulin secretion of the ␤-cell in nonstressful metabolic conditions in mice (7, 8) . Both its membership in the nuclear hormone receptor family and the dissimilar expression pattern of specific isoforms in various tissues suggest HNF4␣ as a potential drug target (9, 10) . In the current study, we overexpress an isoform of HNF4␣ physiologically expressed in the pancreas (HNF4␣8) specifically in human ␤-cells and demonstrate that HNF4␣8-overexpression alone and in combination with other mitogenic factors is sufficient for cell cycle entry. We further demonstrate that the previously unacknowledged analysis of the DNA damage response is critical for the evaluation of mitogenic signals in human ␤-cells.
Results

HNF4␣ High ␤-cells incorporate bromodeoxyuridine (BrdU) in a punctate, not diffuse, manner
Immunofluorescent analysis of adult human cadaveric islets was performed to confirm expression of HNF4␣ in human ␤-cells. HNF4␣ was detected in ␤-cells, albeit at low and variable levels between individual ␤-cells (Supplemental Fig. 1A published on The Endocrine Society's Journals Online web site at http://mend. endojournals.org). We next investigated whether Immunofluorescence staining of Pdx1 (green), BrdU (red), and DAPI (blue) in primary human islets (A) not transduced with adenovirus, (B) transduced with AdCMV-eGFP, and (C) transduced with AdRIP-hHNF4␣8. C (inset), An example of a nucleus exhibiting punctate BrdU incorporation (red) overlapping with DAPI-dimished regions (blue). Immunofluorescence staining of punctate BrdU incorporation (red) and DAPI (blue) with (D) insulin (green), (E) glucagon (green), and (F) somatostatin (green) cells in primary human islets overexpressing HNF4␣8. Similarly, detection of diffuse BrdU incorporation (red) and DAPI (blue) with (G) insulin (green), (H) glucagon (green), and (I) somatostatin (green) cells in AdRIP-hHNF4␣8transduced human islets. I (inset), An example of two DAPI-stained (blue) nuclei showing diffuse BrdU incorporation (red). J, Quantification of the percentage of Pdx1 ϩ cells that are either BrdU ϩ,diffuse or BrdU ϩ,punctate in untransduced, AdCMV-eGFP, and AdRIP-hHNF4␣8transduced islets (HNF4␣8, BrdU ϩ,punctate group is statistically significantly higher compared with all other groups; *, P Ͻ 0.001 as determined by one-way ANOVA with Tukey post hoc test; n ϭ 3 for each group). K, Quantification of the percentage of insulin ϩ , glucagon ϩ , or somataostatin ϩ cells that are either BrdU ϩ,diffuse or BrdU ϩ,punctate in AdRIP-hHNF4␣8transduced islets (insulin ϩ , BrdU ϩ,punctate group is statistically significantly higher compared with all other groups; *, P Ͻ 0.001 as determined by one-tailed ANOVA with Tukey post hoc test; n ϭ 3-4 for each hormone ϩ population). Detection of HNF4␣ (green), BrdU (red), and DAPI (blue) in primary human islets (L) not transduced with adenovirus, (M) transduced with AdCMV-eGFP, and (N) transduced with AdRIP-hHNF4␣8. O, Quantification of the percentage of either BrdU ϩ,diffuse or BrdU ϩ,punctate cells that are HNF4␣ High in AdRIP-hHNF4␣8-transduced islets. (*, P Ͻ 0.001; n ϭ 4 each BrdU incorporation pattern). P, Quantification of the percentage of HNF4␣ High cells are BrdU ϩ,punctate in nondiabetic or type 2 diabetic human islet donations transduced with in AdRIP-hHNF4␣8 (n ϭ 3-4 for each diabetic status). All primary human islets were harvested 72 h after transduction. 
HNF4␣ High ␤-cells do not progress through the cell cycle
To investigate whether HNF4␣8 overexpression is sufficient for cell cycle progression in ␤-cells, we analyzed Ki67 expression. Surprisingly, 72 h after transduction, HNF4␣ High Pdx1 ϩ cells were not Ki67 ϩ (0.06 Ϯ 0.03% of Pdx1 ϩ cells were Ki67 ϩ ) similar to the situation in untransduced or AdCMV-eGFP treated controls (Supplemental Fig. 2 , A-D). We considered the possibility that HNF4␣8-induced proliferation was completed before the 72 h, and collected HNF4␣8-overexpressing islets exposed to continuous BrdU at various time points after transduction (24, 30, 36, 42, and 48 h) . The BrdU incorporation rate into HNF4␣ High ␤-cells was negligible until 36 h after transduction and increased until 48 h, with no further increase at 72 h, suggesting that entry into S-phase occurred between 36 and before 48 h (Supplemental Fig. 2 , E-H). Strikingly, HNF4␣ High ␤-cells did not express Ki67 at any time point (Supplemental Fig. 2 , I-L). Thus, although a subset of HNF4␣ High ␤-cells attempt S-phase, the lack of Ki67 expression suggests activation of a cell cycle arrest mechanism.
We hypothesized that the manner of BrdU incorporation can demarcate cell populations with different DNA replication kinetics. Within the HNF4␣8-transduced islet, BrdU-incorporation patterns distinguished nonendocrine islet cells (marked by BrdU ϩ,diffuse cells) and HNF4␣ High cells induced to enter S-phase (marked by BrdU ϩ,punctate cells), as mentioned above. Thus, we evaluated both diffuse and punctate BrdU-positive populations with various cell cycle markers to discern differences in cell cycle progression (cell marker validation is shown in Supplemental Fig. 2 , M-O). The majority of cells that incorporated BrdU diffusely expressed Ki67 at 24, 30, 36, and 42 h at a high percentage, but not at 48 and 72 h, indicating exit from the cell cycle. In contrast, cells that incorporated BrdU in a punctate manner expressed Ki67 at a very low frequency ( Fig. 2 , A-D). The rare cells exhibiting both BrdU ϩ,punctate and Ki67 expression did not show characteristically large BrdU domains overlapping with reduced regions of DAPI signal, and their pattern of BrdU incorporation most likely reflected incomplete Sphase progression of nonendocrine islet cells at the time of islet harvest (14, 15) . Furthermore, at the 42-h time point, HNF4␣8 overexpression never induced the expression of Cyclin A in BrdU ϩ,punctate cells, a marker of S-phase, G 2phase, and early M-phase (16) , whereas BrdU ϩ,diffuse cells were Cyclin A positive ( Fig. 2 punctate incorporation pattern was the result of cell cycle entry. We used minichromosome maintenance 7 (Mcm7), a DNA replication licensing factor whose expression is activated in early G 1 -phase, when Ki67 is not expressed (17) , to assess initiation of cell cycle progression. The majority (52 Ϯ 6.3%) of BrdU ϩ,punctate singlets indeed expressed Mcm7 at 42 h after transduction, similar to their BrdU ϩ,diffuse cellular counterparts ( Fig. 2 , H-J). Together, these data suggested that unlike BrdU ϩ,diffuse cells, which successfully progress through the cell cycle, BrdU ϩ,punctate cells enter the cell cycle, attempt S-phase and arrest.
To assess whether HNF4␣ High ␤-cells activate cell cycle checkpoints, we used phospho-Chk2 (Thr68) and phospho-p53(Ser15) staining, and the expression of tumor suppressors p16 INK4a and p53, known to contribute to cell cycle arrest in ␤-cells (18, 19) . Expression of both checkpoint markers phospho-Chk2(Thr68) and phospho-p53(Ser15) was present in BrdU ϩ,punctate cells (73.4% Ϯ 2.2 and 78.7% Ϯ 7.5, respectively), but not in BrdU ϩ,diffuse cells 48 h after transduction ( Fig. 2 , K-O). p53 expression was present on the protein level in AdRIP-HNF4␣8 treated islets as indicated by Western blot analysis (Supplemental Fig. 2P ). When quantified by immunostaining, p53 was easily detectable in BrdU ϩ,punctate cells at 48 and 72 h after transduction, with 78.2% Ϯ 6.6 and 73.3% Ϯ 5.1 staining positive, respectively ( Fig. 2 , P-R). We also found p16 INK4a expression in BrdU ϩ,punctate cells at 48 and 120 h after transduction (Fig. 2 , S and T). Thus, although HNF4␣8 was sufficient to stimulate a percentage of transduced ␤-cells to enter the cell cycle, it also activated a checkpoint response. The activation of tumor suppressor genes indicated a failure to complete the cell cycle by the HNF4␣ High , BrdU ϩ,punctate population.
Overexpression of HNF4␣8 leads to activation of the DNA damage response associated with replication stress
The punctate manner of BrdU incorporation into HNF4␣8-overexpressing ␤-cells is reminiscent of the patterns of DNA replication seen during S-phase in mamma- (15, 20) . Although BrdU ϩ,punctate cells are able to license their DNA for replication, as demonstrated by increased Mcm7 expression, the appearance of large punctate domains points to misregulation of the licensing system, allowing cells to inappropriately relicense their already replicated DNA (14) . Phosphorylation of Chk2 on threonine 68 and p53 on serine 15 are downstream substrates of Ataxia telangiectasia mutated, a key mediator of the DNA damage response, and these modifications ultimately lead to the stabilization and subsequent accumulation of p53 protein (21, 22) . We hypothesized that overexpression of HNF4␣8 caused repeated licensing of DNA replication from single origins (or rereplication), resulting in enlarged punctate foci, doublestranded DNA breaks (defined here as replication stress), and induction of the DNA damage response. Therefore, we assessed the effects of HNF4␣8 overexpression on phosphorylation of histone H2AX (␥H2AX), an indicator of DNA double-stranded breaks (23) . Indeed, overexpression of HNF4␣8 caused a dramatic increase in the number of ␥H2AX ϩ Pdx1 ϩ cells, with 4.4% Ϯ 1.4 of Pdx1 ϩ cells colocalizing with ␥H2AX 72 h after transduction, whereas less than 0.5% of Pdx1 ϩ cells stained for ␥H2AX in untransduced or CMV-eGFP-treated controls ( Fig. 3 , A-D). In AdCMV-eGFP transduced islets, ␥H2AX colocalized with cells positive for green fluorescent protein (GFP), reflecting rare toxicity of this adenovirus to islet cells ( Fig. 3B, inset) . The accumulation of ␥H2AX ϩ in Pdx1 ϩ cells mirrored the accrual of BrdU ϩ,punctate in Pdx1 ϩ cells, demonstrating that the DNA damage response was restricted to this cell population ( Fig. 3D ). Indeed, ␥H2AX expression was present in 9.50% Ϯ 1.97 HNF4␣ High cells and 88.1% Ϯ 5.6 of BrdU ϩ,punctate cells at 72 h after transduction and was sustained for up to 120 h ( Fig. 3 , E-J). No significant number of BrdU ϩ,diffuse cells expressed ␥H2AX during either time point ( Fig.  3J ). Many HNF4␣ High BrdU ϩ,punctate cells showed enlarged, dysmorphic nuclei not present in control islets (Fig. 3G , inset), suggesting that HNF4␣8-overexpression in ␤-cells stimulated doublestranded DNA damage that was not repaired over time, leading to a sustained DNA damage response.
To assess whether DNA damage was indeed associated with rereplication, we pulse labeled HNF4␣8 transduced islets between 36 and 48 h, the established time of thymidine incorporation, sequentially with BrdU and EdU (5ethynyl-2=-deoxyuridine) (Supplemental Fig. 3A ). We confirmed absence of cross-reactivity between the two thymidine analogs by labeling HNF4␣8-transduced islets with either BrdU-only or EdU-only, and using detection methods for both thymidine analogs simultaneously Fig. 3 , B-C''). To demonstrate occurrence of rereplication, we varied the nonlabeling times between pulses (1, 3, and 6 h). Rereplication is defined here as the incorporation of both BrdU and EdU into the same locus. Several patterns of thymidine analog incorporation were observed. In HNF4␣8-transduced islets with a 1-h nonlabeling interval, thymidine-analog ϩ cells incorporated a single analog in a diffuse manner (possibility no. 1), undergoing S-phase during the first or second labeling period ( Fig. 3 , K-K''). Thymidine-analog ϩ cells also incorporated both analogs in mutually exclusive areas in a diffuse manner (possibility no. 2), representing a cell undergoing proper S-phase during both labeling periods ( Fig. 3 , L-L''). The percentages of cells with diffuse thymidine analog incorporation integrating only one analog increased with increased nonlabeling interval, as expected (Supplemental Fig. 3D ). Strikingly, in the thymidineanalog ϩ,punctate domains, we saw overlapping incorporation of both EdU and BrdU into at least one focus per nucleus, regardless of the length of the nonlabeling interval (possibility no. 3), demonstrating rereplication ( Fig. 3 , M-O''). 87.9% Ϯ 7.5, 89.8% Ϯ 6.9, and 83.3% Ϯ 8.4 of all thymidine-analog ϩ,punctate cells showed rereplication with a 1-, 3-, and 6-h pulse, respectively (Supplemental Fig. 3E ). These data suggest that replication stress prompted an uncoupling of the mechanisms that controls the replication timing program during S-phase, leading to both DNA damage and subsequent activation of the checkpoint response exhibited in HNF4␣ High BrdU ϩ,punctate ␤-cells.
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Partial loss of lineage fidelity, independent of apoptosis, in ␤-cells overexpressing HNF4␣8
Once expressed, p53 functions as an integrator of diverse stress signals into different cellular outcomes, including cell cycle arrest, senescence, DNA repair, and apoptosis (24, 25) . Sustained mitogenic signaling in the ␤-cell can cause apoptosis (26) . We used the TUNEL assay to determine whether HNF4␣ High BrdU ϩ,punctate ␤-cells succumb to cell death. Pdx1 ϩ cells rarely exhibited TUNEL staining in untransduced, eGFP-overexpresssing, and even HNF4␣8-overexpressing islets 72 h after transduction (Fig. 4, A-D) . The percentage of HNF4␣ High cells that were TUNEL ϩ was only 1.2% Ϯ 0.4 at 72 h and 1.1% Ϯ 0.1 at 120 h after transduction ( Fig. 4 , E-G). Whereas there was a very low level of BrdU ϩ,diffuse cells that were TUNEL ϩ , the percentage of BrdU ϩ,punctate cells that were TUNEL ϩ was only 9.8% Ϯ 5.0, and 12.7% Ϯ 9.9 at 72 and 120 h after transduction, respectively ( Fig. 4 , H-J), demonstrating that apoptosis was not the predominant fate of HNF4␣ High BrdU ϩ,punctate ␤-cells.
The inability of the ␤-cell to repair DNA damage over time may lead to cellular senescence and loss of gene expression required for maintaining the ␤-cell terminal differentiated state (19, 27, 28) . Indeed, we detected some BrdU ϩ,punctate cells positive for senescence associated ␤-galactosidase activity 72 h after transduction (Supplemental Fig. 4, A and B) . To determine whether a sustained DNA damage response was accompanied by loss of differentiation, we analyzed the expression of two transcription factors required for ␤-cell maturation, Nkx6.1 and MafA, by immunofluorescence (29 -31) . Remarkably, there was a time-dependent decrease of Nkx6.1 expression in BrdU ϩ,punctate ␤-cells, with only 20% of the cells retaining Nkx6.1 5 d after viral transduction ( Fig. 4 , K-M). Although we did not record a similar temporal decrease in MafA production, there were a significant number of BrdU ϩ,punctate ␤-cells without detectable MafA expression at both 72-h and 120-h time points (Fig. 4 , N-P).
To assess the effect of HNF4␣-overexpression on ␤-cell function, we performed static glucose-stimulated insulin assays. The absolute amount of insulin released upon glucose stimulus by AdRIP-HNF4␣8 treated islets was not statistically different from untransduced, Ad-CMV-eGFP treated islets and untransduced islets at receipt of donation (Supplemental Fig. 4C ). Also, there were no statistical differences in insulin content in any of the aforementioned groups 72 h after transduction (Supplemental Fig. 4D ), suggesting no loss of ␤-cell function or dedifferentiation in ␤-cells overexpressing HNF4␣8. However, it was not possible to assess the function of the small HNF4␣ High BrdU ϩ,punctate ␤-cell population sepa- Mol Endocrinol, September 2012, 26 (9):1590 -1602 mend.endojournals.org rate from the remainder of the islet; thus, loss of function in these cells remains a likely possibility as, in fact, indicated by the overall deterioration of ␤-cell lineage marker expression described above.
HNF4␣8 synergizes with known factors sufficient for promoting cell cycle entry in the human ␤-cell
Although HNF4␣8 was not sufficient to promote full ␤-cell replication alone, we hypothesized that overexpression of HNF4␣8 might augment human ␤-cell proliferation stimulated by Cdk6 and Cyclin D3 (5) . The overexpression of Cdk6 and Cyclin D3 caused a significant increase in the number of Pdx1 ϩ cells that also expressed Ki67 (3.1% Ϯ 0.8 of Pdx1 ϩ were Ki67 ϩ,total ) ( Fig. 5A) . Strikingly, when we applied HNF4␣8, Cdk6, and Cyclin D3 adenoviruses together, we saw a further increase in the number of Pdx1 ϩ cells that were in the cell cycle 72 h after transduction (8.0% Ϯ 2.2 of Pdx1 ϩ were Ki67 ϩ,total ) ( Fig. 5, B and C, left graph). This finding suggested that HNF4␣8 overexpression in combination with known cell cycle regulators is a mitogenic signal sufficient to increase the number of human ␤-cells initiating cell cycle progression.
However, the majority of Pdx1 ϩ cells exhibited irregular Ki67 staining in islets transduced with Cdk6, Cyclin D3, and HNF4␣8 (Fig. 5, B and C right graph) , unlike the normal Ki67 staining pattern observed in cycling nonendocrine cells (refer to arrows in Fig. 2 Fig. 2 , A and C). We hypothesized that although the triple transgene transduction scheme is sufficient to push more ␤-cells into the cell cycle, it incites an insult that leads to initiation of cell cycle arrest. Therefore, we assessed the fate of the additional Ki67 ϩ Pdx1 ϩ cells when overexpressing HNF4␣8, Cdk6, and Cyclin D3, by analyzing the HNF4␣ High ␤-cell population for cell cycle progression, DNA damage, and apoptosis 72 h after transduction. Indeed, 20.2 Ϯ 5.8% of HNF4␣8 overexpressing cells were Ki67 ϩ and almost always exhibited an irregular Ki67 staining pattern (Fig.  5, D and F) . In line with this finding, only 3.2 Ϯ 0.8% of HNF4␣8-overexpressing cells were Cyclin A ϩ (Fig. 5, E and G) . Cyclin A ϩ cells not colocalizing with HNF4␣ High cells could reflect cells transduced with either Cdk6 and/or Cyclin D3 only, because their overexpression is based on a CMV-promoter ( Fig. 5E ). However, whereas this was an improvement relative to the lack of cell cycle progression seen when overexpressing HNF4␣8 alone, the HNF4␣ High cell population in the triple-transduction experiment was frequently positive for ␥H2AX (37.6% Ϯ 6.4) and TUNEL (44.6% Ϯ 3.4) ( Fig. 5, H-K) . Additionally, these TUNEL ϩ cells exhibited nuclear blebbing surrounding a central region of reduced DAPI staining (Fig.  5I, inset) . The higher percentage of the HNF4␣ High cells exhibiting ␥H2AX and TUNEL compared with Ki67 expression suggests that double-stranded DNA damage-induced apoptosis is the predominant fate of the Ki67 ϩ Pdx1 ϩ cell population over time.
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Overexpression of Cyclin D3 and Cdk6 also activates the DNA damage response in human ␤-cells
Closer examination of cycling Pdx1 ϩ cells in Cdk6and Cyclin D3-transduced islets revealed that a significant proportion of these cells also exhibited an irregular Ki67 staining pattern 72 h after transduction (Fig. 5C,  right graph) . We investigated whether ␤-cells induced to proliferate by overexpression of Cdk6 and Cyclin D3 alone exhibited expression of ␥H2AX at the 72-h time point. Indeed, 9.9 Ϯ 2.3% and 9.0 Ϯ 1.8% of Pdx1 ϩ and insulin ϩ cells, respectively, were positive for ␥H2AX 72 h after transduction, suggesting that a high percentage of ␤-cells driven into the cell cycle by Cyclin D3 and Cdk6 are prone to accumulate DNA damage over time (Fig. 6 , A-C). To assess whether ␥H2AX accumulation was specific to cells having entered the cell cycle sometime during the 72-h time period, we evaluated whether BrdU-and Ki67-positive populations exhibited ␥H2AX expression, and also the percentage of ␥H2AX ϩ cells that incorporated BrdU or expressed Ki67. We closely examined the types of possible BrdU and Ki67 staining patterns for each case. Although not all BrdU ϩ cells were ␥H2AX ϩ (Fig.  6D, inset) , a significant percentage of cells having progressed through S-phase expressed ␥H2AX (60.6 Ϯ 11.5% of BrdU ϩ,total were ␥H2AX ϩ ) and exhibited punctate-like BrdU incorporation (83.9 Ϯ 2.4% BrdU ϩ,punctate were ␥H2AX ϩ ) (Fig. 6, D and F) . The irregular Ki67 staining pattern was also observed in human islets transduced with Cdk6 and Cyclin D3, and colocalized with ␥H2AX expression (91.2 Ϯ 2.1% Ki67 ϩ,irregular cells were ␥H2AX ϩ ) (Fig. 6, E and F) . Only a negligible fraction of either BrdU ϩ,diffuse or Ki67 ϩ,normal were ␥H2AX positive, suggesting that, in line with the overall ability of Cdk6 in combination with a D-cyclin partner to improve human islet function in vivo, a fraction of functional ␤-cells do arise by Cdk6-and Cyclin D3-stimulated proliferation, although DNA damage analysis at a later time point has not been performed (Fig. 6F) (5) . Similarly, the ␥H2AX-positive population was enriched with cells demonstrating punctate-like BrdU incorporation patterns (82.3 Ϯ 7.5% of ␥H2AX ϩ were BrdU ϩ,punctate ) similar to what was seen in ␤-cells when overexpressing HNF4␣8 alone, but not diffuse BrdU incorporation (5.23 Ϯ 2.2% of ␥H2AX ϩ were BrdU ϩ,diffuse ) or a normal Ki67 staining pattern (3.0 Ϯ 0.8% of ␥H2AX ϩ were Ki67 ϩ,normal ) ( Fig.  6D, D inset, and panels E and G). Furthermore, the percentage of ␥H2AX ϩ cells that incorporated BrdU in a punctate-like manner was much higher than the percentage that expressed Ki67 irregular (13.9 Ϯ 1.0% ␥H2AX ϩ were Ki67 irregular ) at 72 h (Fig. 6, E and G) . Also, ␥H2AX ϩ , BrdU ϩ,punctate cells morphologically exhibit nuclear blebbing, indicating apoptosis (Fig. 6E, inset) . Based on cell cycle arrest seen in ␤-cells overexpressing HNF4␣8 alone and the fate of HNF4␣ High cells in the triple-transduced condition, this suggests a cell cycle delay in the subpopulation of transduced ␤-cells accumulating double-stranded DNA damage, ultimately resulting in apoptosis. Indeed, cells incorporating BrdU in a punctate-like manner were positive for the checkpoint marker, phospho-p53 (99.0 Ϯ 0.7% of BrdU ϩ,punctate were phospho-p53(Ser15) ϩ ), whereas of cells incorporating BrdU in a diffuse manner only 5.5 Ϯ 1.4% of BrdU ϩ were phospho-p53(Ser15) ϩ 72 h after transduction (Fig. 6, H and I) . Together, these findings demonstrate that although human ␤-cells can be stimulated to enter in and progress through the cell cycle by overexpression of Cdk6, Cyclin D3, and further with the addition of HNF4␣8, the activation of the DNA damage response highlights the importance of using multiple experimental criteria to adequately assess human ␤-cell expansion.
Discussion
In this study we investigated whether an islet-expressed isoform of the transcription factor HNF4␣ can promote proliferation in primary human ␤-cells. It has been previously suggested in other cell systems that solely relying on BrdU incorporation into DNA is not sufficient to assess complete cell cycle progression (32) . Indeed, through the use of multiple cell cycle markers and their particular staining patterns, in addition to BrdU, we found that overexpression of HNF4␣8 was sufficient to initiate only partial cell cycle completion in a subset of transduced human ␤-cells. The varying response of human ␤-cells to HNF4␣8-overexpression is illustrated in Fig. 7 . We provide further evidence that attempts to mimic complete cell cycle transit in human ␤-cells by induced transcriptional activation uncouples the normally regulated timing at which different chromosomal domains initiate replication during S-phase. Although such an uncoupling event has been achieved before in Xenopus egg extracts by modulating Cdk activity (14) , what regulates the replication timing program specifically in pancreatic ␤-cells is unknown. To ensure that DNA is precisely duplicated during S-phase, the cell must be able to distinguish between replicated and unreplicated DNA. The licensing of origins during G 1 -phase by the binding to DNA of Mcm2-7 proteins and their subsequent removal after initiation of DNA replication ensures proper initiation of DNA replication only once per locus (33) . HNF4␣ High BrdU ϩ,punctate cells were unable to accomplish strict duplication of the genome. Rather, by utilizing two thymidine analogs we detected the occurrence of rereplication as distinct overlapping foci within thymidine ϩ punctate domains. We suggest that the inappropriate relicensing of already replicated DNA, and subsequent firing of DNA replication more than once per locus during S-phase (represented by the punctate BrdU incorporation pattern) leads to the excision of double stranded DNA fragments, and activation of a DNA damage-associated cell cycle arrest mechanism. Such a DNA damage insult and its effect in halting cell cycle transit are seen in studies of other DNA licensing factors in Xenopus egg extracts. Overexpression of Cdt1 (chromatin licensing and DNA replication factor 1) in the G 2 -phase of the cell cycle induced rereplication of DNA, activated checkpoint pathways, and blocked further cell cycle progression. Intriguingly, not only was the checkpoint activation a direct result of multiple rounds of DNA rereplication, but it coincided with the appearance of significant doublestranded DNA fragments, consistent with a model of head-to-tail replication fork collision (34) . Also, increased expression of Cdt1 and subsequent rereplication occurs in human cancer-derived cell lines upon accumulation of constitutively active mutant form of Cyclin D1 (35) . Both activation of the DNA damage checkpoint markers p-Chk2 (Thr68) and p-p53 (Ser15), and expres-sion of ␥H2AX, occurred in the BrdU ϩ,punctate subpopulation of HNF4␣ High ␤-cells. Activation of the DNA damage response did not cease over time, suggesting that the DNA damage is too great to repair, preventing any initially cycling HNF4␣8transduced ␤-cell to successfully complete the cell cycle in a regulated manner.
Activation of the DNA damage response in human ␤-cells is not a phenotype specific to HNF4␣8 overexpression. Indeed, a significant proportion of ␤-cells stimulated to progress through the cell cycle by overexpression of Cdk6 and Cyclin D3 alone also exhibited punctate BrdU incorporation, activation of ␥H2AX expression, an irregular nuclear pattern of Ki67 expression, and checkpoint activation. Although we suggest that a doublestranded DNA damage insult leads to activation of the cell cycle arrest response, identification of the exact DNA damage mechanism requires further investigation (36) . We conclude that in comparison with cycling nonendocrine islet cells, human ␤-cells not only possess innate resistance to entering the cell cycle, but are sensitive to accumulating DNA damage when successfully forced into the cell cycle, as very recently suggested in (37) , becoming increasingly predisposed to undesired endpoints such as apoptosis and loss of ␤-cell differentiation status. Furthermore, genomic instability within ␤-cells might have clinical relevance in the pathophysiology of type 2 diabetes. A mouse model globally deficient in nonhomologous end-joining and expressing a hypomorphic mutant of p53 becomes defective in apoptosis but not in cell cycle arrest and develops diabetes. In these mice, ␤-cell mass is progressively depleted due to double stranded DNA damage-induced senescence (19) . Strikingly, HNF4␣ High BrdU ϩ,punctate ␤-cells exhibited activation of p53 expression but did not undergo apoptosis. Rather, over time HNF4␣8-overexpressing cells attempting cell cycle progression began to lose their ␤-cell lineage fidelity, highlighted by the significant loss of ␤-cell maturation gene expression (Nkx6.1 and MafA), as also seen in the db/db diabetic mouse model (38) . Finally, these phenotypes in the ␤-cell are consistent with the ability of oncogenes to promote senescence by stimulating the DNA damage response through rereplication (39 -41) , for which pathways encompassing key downstream tumor suppressors p53 and Rb are necessary (42) . The majority of HNF4␣8-overexpressing cells do not show any attempt at cell cycle entry and progression. Right column, However, some of the HNF4␣ High ␤-cells are able to initiate cell cycle entry but activate cell cycle arrest programs such as the DNA damage response in an attempt to fix an apparent S-phase insult (exemplified by punctate thymidine analog domains). Asterisk, CyclinD3/Cdk6-and CyclinD3/Cdk6/HNF4␣8-overexpressing ␤-cells fall into the latter category as they do show signs of active cell cycling and DNA damage response. However, the successful ability of these cycling ␤-cells to halt cell cycle progression upon double stranded DNA damage might vary depending on the cocktail of genes being constitutively overexpressed.
The MAPK pathway, dependent on HNF4␣ during pregnancy in the murine ␤-cell in vivo (7) , can also induce cell cycle arrest and subsequent senescence when deregulated via the increase of both p53 and p21 expression and blocks in hyperphosphorylation of Rb (43) . It is therefore tempting to speculate that HNF4␣8 overexpression in the ␤-cell activates this signaling pathway similar to the oncogenes Ras and Mos (44) . Indeed, rodent insulinoma cell lines show not only activation of cyclins and cdk, but also increased expression of cell cycle inhibitors (45) . Conversely, ablation of Rb and p130 in ␤-cells does not lead to a net change in ␤-cell mass despite dramatically increasing ␤-cell proliferation in vivo (46) . Instead, increased ␤-cell proliferation is associated with increased expression of p-p53 (Ser15) and p21 and matched by ␤-cell death. We propose that the accumulation of DNA damage resulting from replication stress is a barrier to efficient human ␤-cell proliferation in vitro. Therefore, as a cautionary note, the criteria for demonstrating sufficiency of a factor to promote ␤-cell proliferation should be extended to include a detailed analysis of cell cycle entry, the fidelity of duplication of the genome during S-phase, progression through multiple cell cycle phases, and cell cycle exit. Furthermore, activation of the DNA damage response should be assessed in future attempts to faithfully mimic ␤-cell proliferation in vitro.
Materials and Methods
Adenovirus production
The original cDNA plasmid, pcDNA3.hHNF4␣8 (NM_ 175914.3), was constructed by Dr. Jerome Eeckhoute (47) and is a kind gift of Dr. Frances M.
Sladek. An adenovirus containing the islet-expressed human HNF4␣8 cDNA and the rat insulin promoter was amplified, purified, and titered.
Culturing, transduction, and harvest of human cadaveric islets
Human islets were supplied by the DERC of the University of Pennsylvania, the National Disease Research Interchange (NDRI) (http://www.ndriresource.org), and the Methodist Hospital Research Institute (http://www.methodisthealth.com/default.cfm). Available information of each human islet donation used and the contribution of each donation to each experiment can be found in Supplemental Table 2 . Islets were incubated in CMRL 1066 medium (Mediatech, Manassas, VA) containing 5.5 mM D-glucose, 0.5% human albumin (Talecris Biotherapeutics, Research Triangle Park, NC), 10 U/ml Heparin (Sagent Pharmaceuticals, Schaumberg, IL), 100 g/ml penicillin/streptomycin, and 2 mM L-glutamine. Islets were transduced with adenoviruses for 24 h followed by washing. Islets were then cultured in the continued presence of the BrdU reagent (Invitrogen, Carlsbad, CA) during the length of incubation after transduction; 5 ϫ 10 6 infectious particles per islet of AdRIP-HNF4␣8, AdCMV-eGFP, and 5 ϫ 10 5 infectious parti-cles per islet of both AdCMV-Cyclin D3 and AdCMV-Cdk6 were used. Islets were fixed in 4% paraformaldehyde for 1 h at 4 C, paraffin embedded, and sectioned.
mRNA isolation and RT-PCR
Total RNA was isolated, cDNA was synthesized, and quantitative PCR were performed as described previously (48) . PCR primer sequences used for E1A are as designed in Ref. 49 : HNF4␣ forward, TGCCTACCTCAAAGCCATCAT and reverse, GCGGTCGTTGATGTAGTCCTC.
Immunofluorescence analysis
Antigen retrieval was performed by pressure cooker heating (Prestige Medical, Northridge, CA) using citrate buffer (pH 6.0). Sections were blocked with CAS-Block (Invitrogen) and incubated with primary antibodies at 4 C overnight (Supplemental Table 1 ). Secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) were added for 2 h at room temperature, and nuclei were stained with DAPI. Highresolution images were taken on a Yokagawa CSU-10 spinning disk mounted on a Nikon Ti-U inverted microscope, and a Hamamatsu Photonics Orca Charge-Coupled Device Camera (Hamamatsu, Bridgewater, NJ).
Terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling (TUNEL)
Apoptosis was assessed by TUNEL (Roche Applied Science, Minneapolis, MN) (50).
Glucose-stimulated insulin secretion in vitro
Glucose-stimulated insulin secretion was performed under static conditions (51) . Insulin release and content was determined using RIA (Millipore Corp., Bedford, MA).
Rereplication assay
BrdU was added to the islet culture, 36 h after adenoviral transduction, for 5.5 h. BrdU was removed by washing, and islets were placed back into fresh medium for 1 h to ensure depletion of BrdU. Then EdU (100 M; Invitrogen) was added for an additional 5.5 h before harvest. Nonlabeling intervals of 3 h and 6 h were also used. After antigen retrieval, EdU incorporation was detected with the Click-iT EdU Alexa Fluor 555 imaging Kit (Invitrogen).
Statistics
Statistical analysis was done between two data sets using a one-tailed Student's t test, and between three or more data sets using a one-way ANOVA combined with a Tukey post hoc test. Differences were considered significant when P Ͻ 0.05. Variation measurements are given as SEM unless stated otherwise. and Dr. Heather Collins and the RIA and Biomarkers Core at the University of Pennsylvania DERC for insulin assays. The HNF4␣8 adenovirus was produced by the Penn Vector Core. We acknowledge use of human tissues provided in part by the National Disease Research Interchange (NDRI). The University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases is supported through the NIH by P30-050366, the Biomarkers Core at the University of Pennsylvania DERC by P30-DK-19525, the Penn Vector Core by P30-DK-019525 and NDRI by 5 U42 RR006042. 
